NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011, in San Francisco. Elliott Sigal, M.D., Ph.D., executive vice president, chief scientific officer, and president, Research and Development, will make a formal presentation about the company at 8:30 a.m. PST (11:30 p.m. EST).
Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
KEYWORDS: United States North America California New York
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Research Science